glp 1 and antipsychotics Antipsychotic Weight Gain Metabolic Syndrome (MetS) Treatment of Antipsychotic-Induced Weight Gain
Description
While both medications are highly effective, tirzepatide acts on two hormone pathwaysGLP-1 and GIPallowing it to regulate appetite while also improving insulin sensitivity and fat metabolism

Yanagi S, Sato T, Kangawa K, Nakazato M

Retarutide is a subcutaneously injected tri-agonist (GLP-1/GIP/glucagon receptor) that demonstrated unprecedented levels of weight loss in a relatively short period of time

We examine the compelling evidence supporting GLP-1 receptor agonists (GLP-1RAs) in managing type 2 diabetes (T2D), obesity, and other diseases

3) while preventing progression of fibrosis in people with NASH [149, 150]

Even if Mounjaro is covered by your Aetna plan, you may not get Mounjaro for free
